Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Eva Hambach/AFP/Getty Images

There are 2,807 confirmed hospital cases of lung injury associated with vaping in all 50 states, Washington, D.C. and two U.S. territories, the Centers for Disease Control and Prevention reports as of Feb 18.

What's new: Because of the consistent declines in new EVALI cases since Sept. 2019, as well as the identification of vitamin E acetate as a primary cause of EVALI, Tuesday's report will be the final CDC update on the number of hospitalized EVALI cases and deaths nationally.

By the numbers: The CDC confirmed the death toll has reached 68 people in 29 states and D.C., as of Feb. 18.

  • The influx of cases has slowed considerably since August. But the agency said the decline was due in part to a reporting lag in early December.

The impact: CDC explains the steady drop in cases as likely multifactorial and possibly related to...

  • Public awareness of the risk associated with THC-containing e-cigarettes, vaping and product use.
  • The elimination of vitamin E acetate from some products.
  • Law enforcement response related to illicit products.

Details: CDC, FDA and individual state health officials "have made progress in identifying the cause of EVALI," CDC reports.

  • Nationally, most vaping-related patients with data on how they sourced products reported obtaining THC-containing products from "informal sources," per the CDC. The agency recommends users should consider no longer vaping THC products, rather than its original claim to refrain from e-cigarettes.
  • Vitamin E acetate has been found in product samples tested by FDA and state labs and patient lung fluid samples tested by CDC across the country.
  • Vitamin E acetate is not present in the lung fluid of those who do not have EVALI.
  • Based on several studies, federal health officials found in late 2019 vitamin E acetate in a sample of illicit products in select states and the additive also caused lung fluid in 48 patients out of 51 diagnosed with the vaping illness.

Additional lab tests for 1,782 hospitalized patients took place relating to a variety of vape products used, per CDC figures as of Dec. 17. Based on data released Dec. 3, the majority of people with the pulmonary illness (EVALI) are young males:

  • 78% are under the age of 35, and 67% are males.
  • About 80% reported using products containing THC, 35% reported exclusive use of THC-containing products and 54% reported use of products with nicotine.

Go deeper:

Editor's note: This story has been updated to reflect the latest details. Check back for more.

Go deeper

The Biden climate doctrine emerges at summit

Illustration: Annelise Capossela/Axios

President Biden's climate summit is highlighting a White House approach that blends diplomacy, executive power, salesmanship and a few threats too.

  • Here are a few pillars of the emerging Biden doctrine.

Biden gets mixed grades on revolving door

Illustration: Sarah Grillo/Axios

President Biden is getting mixed marks for his reliance on industry insiders to staff his administration during its first 100 days.

Why it matters: Progressives have leaned on the new president to limit the revolving door between industry and government. A new report from the Revolving Door Project praises him on that front but highlights key hires it deems ethically questionable.

Exclusive: Sen. Coons sees new era of bipartisanship on China

Sen. Chris Coons. Photo: Kent Nishimura / Los Angeles Times via Getty Images

The Jan. 6 insurrection was a "shock to the system," propelling members of Congress toward the goal of shoring up America's ability to compete with China, Sen. Chris Coons (D-Del.) told Axios during an interview Thursday.

Why it matters: Competition between China's authoritarian model and the West's liberal democratic one is likely to define the 21st century. A bipartisan response would help the U.S. present a united front.